Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Female Reproductive SystemDRG 754-malignancy-female-reproductive-system-with-mcc
    Ask Trek AI about this page

    Malignancy, Female Reproductive System with MCC: Inpatient Reimbursement Overview

    DRG 754 addresses malignant neoplasms of the female reproductive system when a Major Complication or Comorbidity is present, encompassing complex gynecologic oncology admissions. Classification matters for inpatient reimbursement because higher clinical severity drives greater resource intensity and a higher Medicare payment weight under the Centers for Medicare & Medicaid Services payment framework.

    Customize your policy alerts

    Sign up for drg 754 policy alerts

    Get alerted when payer policies referencing 754 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 754 Overview

    DRG 754 covers hospital admissions for malignancies of the female reproductive system when a Major Complication or Comorbidity is present, typically including advanced gynecologic cancers with serious associated conditions or treatment complications. This Diagnosis-Related Group groups cases with higher resource use and clinical complexity, which directly impacts Medicare inpatient payment by assigning a higher relative weight compared with less severe reproductive system malignancy groups. Hospitals should recognize that the presence of a Major Complication or Comorbidity influences case classification and reimbursement under the Centers for Medicare & Medicaid Services inpatient prospective payment system. Accurate documentation of diagnoses and procedures is essential to align clinical care with appropriate payment classification.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative optimization and enhanced recovery trials focused on multimodal strategies to reduce immediate postoperative morbidity in patients undergoing surgery for advanced gynecologic malignancies with major complications. These studies enroll hospitalized women with ovarian, uterine, cervical, or vulvar cancers who require cytoreductive, radical, or urgent surgical procedures and present with high-risk features (extensive disease, prior chemo, frailty, or preoperative sepsis). They evaluate interventions such as prehabilitation, standardized anesthesia/analgesia bundles, goal-directed fluid therapy, and early mobilization to shorten length of stay, lower intensive care needs, and reduce in-hospital complication rates—outcomes directly relevant to providers managing complex perioperative care and to payers through potential reduced resource utilization.
    • Comparative effectiveness and sequencing studies of multidisciplinary inpatient treatments for malignancy-related complications that require acute medical management. These trials compare strategies such as inpatient systemic therapy initiation versus delayed adjuvant therapy after stabilization, or interventional radiology procedures versus surgical approaches for tumor-associated bleeding, obstruction, or infection in women with advanced reproductive cancers. The patient population includes hospitalized oncology patients with complications that drive DRG assignment; results inform clinicians about best choices for stabilizing patients and guide payers on cost-effectiveness and resource allocation for competing acute management pathways.
    • Post-discharge outcomes and transitional care trials assessing readmission reduction, survivorship needs, and functional recovery among patients discharged after treatment of gynecologic malignancies with major complications. These studies enroll recently discharged patients—often older and with comorbidities—tracking coordinated home health, early outpatient oncology follow-up, symptom monitoring, and palliative care integration to measure readmissions, quality of life, and downstream outpatient utilization. Findings are important to hospital administrators and payers because they target reductions in costly readmissions and emergency visits while improving long-term outcomes and appropriate use of outpatient resources.

    Related Codes

    734-PELVIC-EVISCERATION-RADICAL-HYSTERECTOMY-AND-RADICAL-VULVECTOMY-WITH-CC-MCC

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy with CC/MCC: Inpatient Reimbursement Overview

    735-PELVIC-EVISCERATION-RADICAL-HYSTERECTOMY-AND-RADICAL-VULVECTOMY-WITHOUT-CC-MCC

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy: Inpatient Reimbursement Overview

    736-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    737-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-CC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    738-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    739-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    740-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITH-CC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    741-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    742-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-MALIGNANCY-WITH-CC-MCC

    Uterine and Adnexa Procedures for Non-Malignancy with CC/MCC: Inpatient Reimbursement Overview

    743-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Non-Malignancy without CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 24

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.